Literature DB >> 33573298

Modeling and Molecular Dynamics of the 3D Structure of the HPV16 E7 Protein and Its Variants.

Ciresthel Bello-Rios1, Sarita Montaño2, Olga Lilia Garibay-Cerdenares1,3, Lilian Esmeralda Araujo-Arcos1, Marco Antonio Leyva-Vázquez1, Berenice Illades-Aguiar1.   

Abstract

The oncogenic potential of high-risk human papillomavirus (HPV) is predicated on the production of the E6 and E7 oncoproteins, which are responsible for disrupting the control of the cell cycle. Epidemiological studies have proposed that the presence of the N29S and H51N variants of the HPV16 E7 protein is significantly associated with cervical cancer. It has been suggested that changes in the amino acid sequence of E7 variants may affect the oncoprotein 3D structure; however, this remains uncertain. An analysis of the structural differences of the HPV16 E7 protein and its variants (N29S and H51N) was performed through homology modeling and structural refinement by molecular dynamics simulation. We propose, for the first time, a 3D structure of the E7 reference protein and two of Its variants (N29S and H51N), and conclude that the mutations induced by the variants in N29S and H51N have a significant influence on the 3D structure of the E7 protein of HPV16, which could be related to the oncogenic capacity of this protein.

Entities:  

Keywords:  E7; HPV; molecular dynamics simulation; variants

Year:  2021        PMID: 33573298      PMCID: PMC7866783          DOI: 10.3390/ijms22031400

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  52 in total

1.  The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.

Authors:  Benyue Zhang; Wei Chen; Ann Roman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-28       Impact factor: 11.205

2.  The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.

Authors:  Ariane L Jansma; Maria A Martinez-Yamout; Rong Liao; Peiqing Sun; H Jane Dyson; Peter E Wright
Journal:  J Mol Biol       Date:  2014-11-01       Impact factor: 5.469

3.  Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.

Authors:  Xin Liu; Adrienne Clements; Kehao Zhao; Ronen Marmorstein
Journal:  J Biol Chem       Date:  2005-10-24       Impact factor: 5.157

4.  Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.

Authors:  E Berezutskaya; B Yu; A Morozov; P Raychaudhuri; S Bagchi
Journal:  Cell Growth Differ       Date:  1997-12

5.  Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes.

Authors:  J T Thomas; W G Hubert; M N Ruesch; L A Laimins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

6.  Examination of the pRb-dependent and pRb-independent functions of E7 in vivo.

Authors:  Scott Balsitis; Fred Dick; Denis Lee; Linda Farrell; R Katherine Hyde; Anne E Griep; Nicholas Dyson; Paul F Lambert
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11.

Authors:  Stephen T Oh; Michelle S Longworth; Laimonis A Laimins
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

8.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.

Authors:  S Chellappan; V B Kraus; B Kroger; K Munger; P M Howley; W C Phelps; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

9.  HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition.

Authors:  Karin Hellner; Jessica Mar; Frank Fang; John Quackenbush; Karl Münger
Journal:  Virology       Date:  2009-06-23       Impact factor: 3.616

Review 10.  Carcinogenic human papillomavirus infection.

Authors:  Mark Schiffman; John Doorbar; Nicolas Wentzensen; Silvia de Sanjosé; Carole Fakhry; Bradley J Monk; Margaret A Stanley; Silvia Franceschi
Journal:  Nat Rev Dis Primers       Date:  2016-12-01       Impact factor: 52.329

View more
  2 in total

Review 1.  Epidemiology and Molecular Biology of HPV Variants in Cervical Cancer: The State of the Art in Mexico.

Authors:  J Omar Muñoz-Bello; Adela Carrillo-García; Marcela Lizano
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

2.  Molecular insights into the interaction of HPV-16 E6 variants against MAGI-1 PDZ1 domain.

Authors:  Lilian Esmeralda Araujo-Arcos; Sarita Montaño; Ciresthel Bello-Rios; Olga Lilia Garibay-Cerdenares; Marco Antonio Leyva-Vázquez; Berenice Illades-Aguiar
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.